Medicaid Denies Nearly Half Of Requests For Hepatitis C Drugs: Study

Researchers at the University of Pennsylvania found that Medicaid turned down requests for new expensive drugs to treat hepatitis C 46 percent of the time, while private insurers barred them 10 percent and Medicare 5 percent.

From: http://www.webmd.com/hepatitis/news/20151120/medicaid-denies-nearly-half-of-requests-for-hepatitis-c-drugs-study?src=RSS_PUBLIC